As regards to proteins, we observed a significantly higher levels in EAAT1, and lower levels in GluN2A and EAAT2 in the DLPFC of schizophrenia patients, compared with non-psychiatric controls (adjusted means [95% CI]; EAAT1: CTRL = 87.8 [59.2–116.3], SCZ = 140.4 [109.7–171.0]% of control, F(1,32) = 5.123, p = 0.031; GluN2A: CTRL = 117.3 [96.2–138.4], SCZ = 76.0 [54.2–97.8]% of control, F(1,35) = 5.965, p = 0.020; EAAT2: CTRL = 97.0 [76.4–117.5], SCZ = 62.6 [42.0–83.2]% of control, F(1,36) = 4.524, p = 0.04; Fig. 3o,c,p, Supplementary Fig. 1, Supplementary Table 5). This evidence concerns the gene SLC1A3 and schizophrenia.